Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-034676
Filing Date
2021-08-31
Accepted
2021-08-31 21:28:15
Documents
1
Period of Report
2021-08-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 14162
  Complete submission text file 0000899243-21-034676.txt   15600
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
Seagen Inc. (Issuer) CIK: 0001060736 (see all company filings)

EIN.: 911874389 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 21823 30TH DR SE BOTHELL WA 98021
Business Address
SIEGALL CLAY B (Reporting) CIK: 0001167496 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-32405 | Film No.: 211228615